::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

PREVALENCE OF METABOLIC SYNDROME IN ADULT POPULATION OF LAHORE

AUTHORS:

Dr Kifayat Hussain Qazalbash, Dr Aqib Hussain, Dr Hina Mukhtar

ABSTRACT:

Aim: To estimate the prevalence of metabolic syndrome (MetS) and its individual components in the adult population. Place and Duration: In the Medicine Unit II of Jinnah Hospital Lahore for one year duration from March 2019 to March 2020. Methods: A total of 630 people over the age of 18 were randomly selected from the primary healthcare register to represent a representative sample of the population in the Tetovo poviat, adjusted for age and gender. MetS is defined according to the definition of the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII). Results: The prevalence of MetS was 28.25%. It was much higher in women than in men (34.06% vs. 22.26%, p = 0.004). The largest number of people from MetS living in rural areas (31.32% vs. 23.60%, p = 0.002). Of the individual components of MetS, 52.06% of the population had elevated blood pressure, 46.35% lowered high-density lipoprotein cholesterol (HDL-C) and 43.17% abdominal obesity (AA). In the female population, abdominal obesity was more dominant (59.38% and 26.54%, p = 0.000), and men were more dominated by increased blood pressure (53.44% and 50.65%, p = 0.48). Conclusion: The prevalence of MetS is high in our society, especially among women. Rates of hypertension and abdominal obesity are among the highest in the region. Advice on diet and lifestyle changes, in addition to drug therapy in this category, would contribute to the prevention of cardiovascular disease, type II diabetes and complications associated with these diseases. Key words: metabolic syndrome, prevalence, abdominal obesity.